| Drug Name |
Fluoxymesterone |
| Drug ID |
BADD_D00934 |
| Description |
An anabolic steroid that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women. |
| Indications and Usage |
In males, used as replacement therapy in conditions associated with symptoms of deficiency or absence of endogenous testosterone. In females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
G03BA01 |
| DrugBank ID |
DB01185
|
| KEGG ID |
D00327
|
| MeSH ID |
D005474
|
| PubChem ID |
6446
|
| TTD Drug ID |
D0L2LS
|
| NDC Product Code |
64181-0082; 0832-0086; 65089-0052 |
| Synonyms |
Fluoxymesterone | Fluoximesteron | Halotestin | Stenox | Android-F | Android F |
